Key terms

About ACET

Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of “off-the-shelf” gamma delta T cells. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest ACET news

Apr 22 4:42pm ET Adicet Bio Showcases Promising ADI-270 Cancer Therapy Data by TipRanks Apr 22 4:35pm ET Adicet Bio’s new preclinical data highlighting ADI-270 selected for ASGCT by TipRanks Apr 02 6:30am ET Analysts Offer Insights on Healthcare Companies: Genelux Corp. (GNLX), Adicet Bio (ACET) and Entera Bio (ENTX) by TipRanks Mar 21 9:05am ET Adicet Bio (ACET) Receives a New Rating from Truist Financial by TipRanks Mar 20 12:26pm ET Adicet Bio: A Strong Buy on Robust Financials and Promising Clinical Trials by TipRanks Mar 20 10:55am ET Buy Rating Affirmed for Adicet Bio Amid Promising CAR T-Cell Therapies and Strong Financial Footing by TipRanks Mar 20 7:25am ET Adicet Bio’s Promising Drug Pipeline and Buy Rating Justification by TipRanks Mar 20 5:56am ET Buy Recommendation for Adicet Bio Amid Promising Autoimmune and Cancer Therapy Developments by TipRanks Mar 20 12:25am ET JMP Securities Keeps Their Hold Rating on Adicet Bio (ACET) by TipRanks Mar 19 4:13pm ET Adicet Bio reports Q4 EPS (69c), consensus (69c) by TipRanks Feb 13 2:02pm ET Adicet upgraded to Buy on cell therapy potential at JonesResearch by TipRanks Feb 13 1:56pm ET Adicet Bio upgraded to Buy from Hold at JonesResearch by TipRanks Feb 02 9:34am ET Adicet Bio price target lowered to $10 from $26 at H.C. Wainwright by TipRanks Jan 25 4:36am ET Adicet Bio Announces Offering Pricing and Cash Position by TipRanks Jan 25 4:36am ET Adicet Bio Launches Public Stock and Warrant Offering by TipRanks

No recent press releases are available for ACET

ACET Financials

1-year income & revenue

Key terms

ACET Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

ACET Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

A bubble tea store operated by Sichuan Baicha Baidao in Shanghai, China, on April 23, 2024.
Raul Ariano/Bloomberg/Getty Images
Is the tea bubble bursting? ChaPanda shares plunge in Hong Kong IPO
People walk past the New York Stock Exchange (NYSE) on April 10, 2024 in New York City.
Spencer Platt/Getty Images
Can markets make a comeback? That depends on tech earnings
People walk past the New York Stock Exchange Thursday, March. 21, 2024.
Yuki Iwamura/AP
Investors are fearful. They shouldn’t be
People walk past the New York Stock Exchange (NYSE) on March 28, 2024 in New York City.
NDZ/STAR MAX/IPx/AP
What stalled this year’s seemingly infallible stock market rally